Chief executive officer

Fuad El-Hibri Announces Emergent BioSolutionsAward to Supply BioThrax Anthrax Vaccine to U.S. Government

 Fuad El-Hibri, chairman and chief executive officer of Emergent BioSolutions Inc.,(NYSE: EBS) announced that, in response to solicitation RFP-2011-N-13414, it has received an award to supply the U.S.

Submitted by admin on Fri, 10/14/2011 - 10:41. categories [ ]

Emergent BioSolutions to Present at Jefferies 2011 Global Healthcare Conference in London

 Emergent BioSolutions Inc. (NYSE: EBS) will be webcasting its presentation at the

Submitted by admin on Wed, 09/21/2011 - 15:23. categories [ ]

Singapore Health Sciences Authority Approves Emergent BioSolutions Anthrax Vaccine, BioThrax

 

Submitted by admin on Thu, 07/07/2011 - 14:56. categories [ ]

Emergent BioSolutions Chairman and CEO Fuad El-Hibri Appointed to U.S. Chamber of Commerce Board of Directors

 

Submitted by admin on Mon, 06/20/2011 - 13:26. categories [ ]

Emergent BioSolutions to Present at Jefferies 2011 Global Healthcare Conference

 
 

Submitted by admin on Wed, 06/01/2011 - 13:43. categories [ ]

Emergent BioSolutions Chairman and CEO Fuad El-Hibri Named Biotech CEO of the Year at the World Vaccine Congress

ROCKVILLE, Md., Apr 12, 2011 (BUSINESS WIRE) — Emergent BioSolutions Inc. (NYSE:EBS) announced today that Fuad El-Hibri, its chairman and chief executive officer, has been recognized as Biotech CEO of the Year during the Vaccine Industry Excellence (ViE) Awards at the World Vaccine Congress.

Submitted by admin on Fri, 04/15/2011 - 12:08. categories [ ]

Emergent BioSolutions to Present Today at Needham & Company Healthcare Conference

Emergent BioSolutions Inc. (NYSE: EBS) will be webcasting its presentation at the 10th Annual Needham & Company Healthcare Conference in New York on Tuesday, April 5, 2011 at 8:00 AM Eastern. During the presentation, a member of the company’s senior management team will provide a corporate overview, which may include a discussion of recent business developments, 2010 financial results and financial guidance for 2011.

Submitted by admin on Tue, 04/05/2011 - 11:27. categories [ ]

Emergent BioSolutions to Release Fourth Quarter and Full Year 2010 Financial Results and Conduct a Conference Call on March 10

ROCKVILLE, Md., Feb 24, 2011 (BUSINESS WIRE) — Emergent BioSolutions Inc. (NYSE:EBS) announced today it will report financial results for the fourth quarter and full year 2010 on Thursday, March 10, 2011, after market close.

Submitted by admin on Fri, 02/25/2011 - 12:14. categories [ ]

CEO took roundabout path to Emergent

By Marjorie Censer
Monday, January 3, 2011
Fuad El-Hibri has lived in all sorts of exotic locales, working for Citicorp in Saudi Arabia, consulting for Booz Allen Hamilton in Indonesia and establishing mobile telecommunications businesses in Russia, Venezuela and El Salvador.

Submitted by admin on Fri, 01/07/2011 - 14:53. categories [ ]

Emergent BioSolutions Completes Acquisition of Trubion Pharmaceuticals

ROCKVILLE, Md., Oct 28, 2010 (BUSINESS WIRE) — Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has completed the acquisition of Trubion Pharmaceuticals, Inc., following a majority vote to approve the merger by Trubion stockholders at a special meeting conducted at Trubion’s Seattle headquarters on October 28, 2010. The acquisition provides Emergent with multiple, advanced stage candidates in the key disease areas of oncology and autoimmunity as well as access to novel and versatile protein therapeutic platforms.

Submitted by admin on Thu, 11/04/2010 - 15:22. categories [ ]
12next ›last »